Safety Study for Short-course Accelerated, Hypofractionated Partial Breast Radiotherapy (APBI) in Women With Early Stage Breast Cancer Using the Contura MLB
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
SenoRx, Inc.
With
C. R. Bard
Age
50–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Life expectancy \> 10 years
Lumpectomy with clear margins (negative per NSABP criteria)
DCIS and/or invasive carcinoma
If invasive, nodes must be negative
T stage is Tis, T1 or T2\<=3 cm max diameter
ER(+) or ER(-)/PR(+)
You may not be if
Pregnant or breast feeding
Active collagen-vascular disease
Paget's disease of the breast
Prior history of breast cancer
Prior breast or thoracic radiotherapy
Multicentric carcinoma
Synchronous bilateral breast cancer
Surgical margins that cannot be assessed or that are positive
T Stage is T2\>3 cm or greater
ER(-)/PR(-)
Clareo Health | Safety Study for Short-course Accelerated, Hypofractionated Partial Breast Radiotherapy (APBI) in Women With Early Stage Breast Cancer Using the Contura MLB
